Source: https://www.scribd.com/document/341762/01798-March06FedReg
Timestamp: 2018-08-19 08:45:28
Document Index: 714208710

Matched Legal Cases: ['§ 994', '§2', '§3', '§3', '§2', '§2', '§2']

01798-March06FedReg | Controlled Substances Act | United States Federal Sentencing Guidelines
01798-March06FedReg
ACTION: Notice of temporary, emergency amendment to sentencing guidelines, policy statements, and commentary.
SUMMARY: Pursuant to the Anabolic Steroid Control Act of 2004, Pub. L. 108–358 (the "ASC Act") and the United States Parole Commission Extension and Sentencing Commission Authority Act of 2005, Pub. L. 109–76, the Commission hereby gives notice of a temporary, emergency amendment to the sentencing guidelines, policy statements, and commentary. This notice sets forth the temporary, emergency amendment and the reason for the amendment.
DATES: The Commission has specified an effective date of March 27, 2006, for the emergency amendment set forth in this notice.
SUPPLEMENTARY INFORMATION: The United States Parole Commission Extension and Sentencing Commission Authority Act of 2005 requires the Commission, under emergency amendment authority, to implement section 3 of the ASC Act no later than 180 days after the date of enactment of the United States Parole Commission Extension and Sentencing Commission Authority Act of 2005. Accordingly, the Commission is required to promulgate a temporary, emergency amendment by March 27, 2006.
AUTHORITY: 28 U.S.C. § 994(a), (o), (p), (x); section 105 of Pub. L. 109–9; and Pub. L. 109–76.
Amendment: Section 2D1.1 is amended by redesignating subsections (b)(6) and (b)(7) as subsections (b)(8) and (b)(9), respectively; and by inserting the following after subsection (b)(5):
If the defendant distributed an anabolic steroid to an athlete, increase by 2 levels.".
Section 2D1.1(c) is amended in the "*Notes to Drug Quantity Table" in subdivision (F) by striking "(except anabolic steroids)"; and by adding at the end the following:
"For an anabolic steroid that is not in a pill, capsule, tablet, or liquid form (e.g., patch, topical cream, aerosol), the court shall determine the base offense level using a reasonable estimate of the quantity of anabolic steroid involved in the offense. In making a reasonable estimate, the court shall consider that each 25 mg of an anabolic steroid is one ‘unit’.".
Section 2D1.1(c) is amended in the "*Notes to the Drug Quantity Table" by striking subdivision (G); and by redesignating subdivisions (H) through (J) as subdivisions (G) through (I), respectively.
The Commentary to §2D1.1 captioned "Application Notes" is amended in the first paragraph of Note 8 by inserting "Interaction with §3B1.3.—" before "A defendant who"; by striking "enhancement" and inserting "adjustment"; and by adding at the end the following:
"Additionally, an enhancement under §3B1.3 ordinarily would apply in a case in which the defendant used his or her position as a coach to influence an athlete to use an anabolic steroid.".
The Commentary to §2D1.1 captioned "Application Notes" is amended in Notes 19 and 20 by striking "(b)(6)" each place it appears and inserting "(b)(8)"; and in Note 21 by striking "(b)(7)" each place it appears and inserting "(b)(9)".
Application of Subsection (b)(6).—For purposes of subsection (b)(6), ‘masking agent’ means a substance that, when taken before, after, or in conjunction with an anabolic steroid, prevents the detection of the anabolic steroid in an individual’s body.
Application of Subsection (b)(7).—For purposes of subsection (b)(7), ‘athlete’
means an individual who participates in an athletic activity conducted by (i) an intercollegiate athletic association or interscholastic athletic association; (ii) a professional athletic association; or (iii) an amateur athletic organization.".
Reason for Amendment: This amendment implements the directive in the United States Parole Commission Extension and Sentencing Commission Authority Act of 2005, Pub. L. 109–76, which required the Commission, under emergency amendment authority, to implement section 3 of the Anabolic Steroid Control Act of 2004, Pub. L. 108–358 (the "ASC Act"). The ASC Act directed the Commission to "review the Federal sentencing guidelines with respect to offenses involving anabolic steroids" and "consider amending the...guidelines to provide for increased penalties with respect to offenses involving anabolic steroids in a manner that reflects the seriousness of such offenses and the need to deter anabolic steroid trafficking and use...."
The amendment implements the directives by increasing the penalties for offenses involving anabolic steroids. It does so by changing the manner in which anabolic steroids are treated under §2D1.1 (Unlawful Manufacturing, Importing, Exporting, or Trafficking (Including Possession with Intent to Commit These Offenses); Attempt or
Conspiracy). The amendment eliminates the sentencing distinction between anabolic steroids and other Schedule III substances when the steroid is in a pill, capsule, tablet, or liquid form. For anabolic steroids in other forms (e.g., patch, topical cream, aerosol), the amendment instructs the court that it shall make a reasonable estimate of the quantity of anabolic steroid involved in the offense, and in making such estimate, the court shall consider that each 25 mg of anabolic steroid is one "unit".
In addition, the amendment addresses two harms often associated with anabolic steroid offenses by providing new enhancements in §2D1.1(b)(6) and (b)(7). Subsection (b)(6) provides a two-level enhancement if the offense involved the distribution of an anabolic steroid and a masking agent. Subsection (b)(7) provides a two-level enhancement if the defendant distributed an anabolic steroid to an athlete. Both enhancements address congressional concern with distribution of anabolic steroids to athletes, particularly the impact that steroids distribution and steroids use has on the integrity of sport, either because of the unfair advantage gained by the use of steroids or because of the concealment of such use.
Documents Similar To 01798-March06FedReg
United States v. Casados, 10th Cir. (2006)
United States v. Abdullah Saubar, A/K/A Auburn Glenn Johnson, 996 F.2d 1209, 1st Cir. (1993)
United States v. Gamble, 10th Cir. (2005)
United States v. Armando Villatoro-Reyes, 11th Cir. (2012)
United States v. Riley, 10th Cir. (1998)
United States v. Ricky Lee Royal, 16 F.3d 413, 4th Cir. (1994)
United States v. Antywan E. Bryant, 11th Cir. (2010)
United States v. Clark McKnight, 92 F.3d 1183, 4th Cir. (1996)
United States v. Martinez-Zamaripa, 680 F.3d 1221, 10th Cir. (2012)
United States v. Lamont Wright, 3rd Cir. (2011)
United States v. William Allen Bowman, United States of America v. William Allen Bowman, 46 F.3d 1127, 4th Cir. (1995)
United States v. Laws, 10th Cir. (2000)
United States v. Taiwo Oladipupo, A/K/A "Oluranti Oguntayo", 346 F.3d 384, 2d Cir. (2003)
United States v. James Corbett Hash, 956 F.2d 63, 4th Cir. (1992)
United States v. Nelson, 1st Cir. (2015)
United States v. Rafael Pena-Gonell, 3rd Cir. (2011)
United States v. West, 643 F.3d 102, 3rd Cir. (2011)
United States v. Jerry Dewayne Harris, 7 F.3d 1045, 10th Cir. (1993)
United States v. Darton, 595 F.3d 1191, 10th Cir. (2010)
Zahedan research medical
United States v. Robert Kelly Bishop, 921 F.2d 1068, 10th Cir. (1991)
United States v. Larry Joseph Leblanc, 169 F.3d 94, 1st Cir. (1999)
United States v. James Sherman Walker, 912 F.2d 1365, 11th Cir. (1990)
United States v. Terry Andrew Wilder, 989 F.2d 497, 4th Cir. (1993)